Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Fusion Pharmaceuticals Inc
(NQ:
FUSN
)
21.55
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Jun 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
21.55
Bid (Size)
21.65 (33)
Ask (Size)
21.87 (1)
Prev. Close
21.55
Today's Range
21.55 - 21.55
52wk Range
2.310 - 21.60
Shares Outstanding
63,846,009
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
FUSION PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Fusion Pharmaceuticals Inc. - FUSN
May 09, 2024
From
Kahn Swick & Foti, LLC
Via
Business Wire
FUSN Stock Earnings: Fusion Pharmaceuticals Misses EPS for Q1 2024
May 07, 2024
FUSN stock results show that Fusion Pharmaceuticals missed analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Performance
YTD
+160.27%
+160.27%
1 Month
N/A
N/A
3 Month
+0.47%
+0.47%
6 Month
+70.36%
+70.36%
1 Year
+595.16%
+595.16%
More News
Read More
Top 4 Health Care Stocks That May Plunge This Month
April 26, 2024
Via
Benzinga
Why Big Pharma Is Following Novartis' Lead In A $25 Billion Market
April 25, 2024
Via
Investor's Business Daily
Recap: Fusion Pharmaceuticals Q4 Earnings
March 20, 2024
Via
Benzinga
Unveiling 11 Analyst Insights On Fusion Pharmaceuticals
March 20, 2024
Via
Benzinga
Kuehn Law Encourages FUSN, KAMN, DRQ, and VZIO Investors to Contact Law Firm
March 19, 2024
Via
News Direct
AstraZeneca Hikes Annual Dividend By 7% Just Before Vote On Its CEO's Pay Package Boost
April 11, 2024
Via
Benzinga
Exposures
Product Safety
AstraZeneca CEO Highlights Decade-Long Sales Goal Of $45B Along With Investor Doubts As It Lags In Weight Loss Race
April 02, 2024
Via
Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AdTheorent Holding Company, Inc. (Nasdaq – ADTH), Agiliti, Inc. (NYSE – AGTI), Landos Biopharma, Inc. (Nasdaq – LABP), Fusion Pharmaceuticals Inc. (Nasdaq - FUSN)
April 01, 2024
From
Brodsky & Smith LLC
Via
GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Agiliti, Inc. (NYSE – AGTI), Landos Biopharma, Inc. (Nasdaq – LABP), Fusion Pharmaceuticals Inc. (Nasdaq - FUSN), Kinnate Biopharma Inc. (Nasdaq – KNTE)
March 25, 2024
From
Brodsky & Smith LLC
Via
GlobeNewswire
FUSN Stock Earnings: Fusion Pharmaceuticals Misses EPS for Q4 2023
March 20, 2024
Via
InvestorPlace
FUSION PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Fusion Pharmaceuticals Inc. - FUSN
March 19, 2024
From
Kahn Swick & Foti, LLC
Via
Business Wire
Nasdaq Turns Higher; Caleres Posts Upbeat Q4 Results
March 19, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Peraso Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
March 19, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
March 19, 2024
Via
Benzinga
Dow Jumps 200 Points; Core & Main Shares Gain After Q4 Results
March 19, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Fusion Pharmaceuticals Inc. (Nasdaq - FUSN), Whole Earth Brands, Inc. (Nasdaq – FREE), Kinnate Biopharma Inc. (Nasdaq – KNTE), Societal CDMO Check Corp. (Nasdaq –
March 19, 2024
From
Brodsky & Smith LLC
Via
GlobeNewswire
National CineMedia Reports Upbeat Results, Joins Nordstrom, Core & Main And Other Big Stocks Moving Higher On Tuesday
March 19, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Fusion Pharmaceuticals Inc. (NASDAQ: FUSN) Records 52-Week High Tuesday Morning
March 19, 2024
Via
Investor Brand Network
Nasdaq Down 100 Points; US Housing Starts Surge In February
March 19, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
March 19, 2024
Via
Benzinga
Fusion Pharma Stock Nearly Doubles After Scoring $2 Billion AstraZeneca Takeover
March 19, 2024
Via
Investor's Business Daily
Why Is Greenwave Tech Solutions (GWAV) Stock Down 53% Today?
March 19, 2024
Via
InvestorPlace
Nvidia To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Tuesday
March 19, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.